Skip header and navigation

Narrow By

45 records – page 1 of 3.

Nutrition guidelines for hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35132
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0628
Available Online
View Pamphlet
This pamphlet is for people with Chronic Kidney Disease (CKD). It gives information about protein, sodium (salt), potassium, and phosphorus, as well as reading food labels, adding calories and flavour, and controlling your fluid intake. A sample meal plan and guidelines for measuring portions are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (29 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Phosphorus, Dietary
Diet, Sodium-Restricted
Renal Dialysis
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Diet therapy
Food--Phosphorus content
Salt-free diet
Hemodialysis
Specialty
Nutrition and food
Abstract
This pamphlet is for people with Chronic Kidney Disease (CKD). It gives information about protein, sodium (salt), potassium, and phosphorus, as well as reading food labels, adding calories and flavour, and controlling your fluid intake. A sample meal plan and guidelines for measuring portions are included.
Notes
Previous title: Nutrition guidelines for kidney disease
Previous title: Diet for kidney disease
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0628
Less detail

Sample meal plan for kidney disease

https://libcat.nshealth.ca/en/permalink/chpams35277
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0652
Available Online
View Pamphlet
This pamphlet gives a 14-day meal plan for people with kidney disease.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Abstract
This pamphlet gives a 14-day meal plan for people with kidney disease.
Notes
Previous title: Sample renal diet plan
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0652
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1445
Available Online
View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Notes
Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail

Pruritis (itchy skin) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams38252
Nova Scotia Health Authority. Renal Pharmacy Team, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2385
Available Online
View Pamphlet
Pruritis is an itchy feeling on or under your skin. This pamphlet explains what causes pruritis in people with CKD, what the symptoms are, how you can prevent it, and how your kidney team will treat it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Pharmacy Team
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases
Pruritis
Subjects (LCSH)
Kidney disease
Skin
Itching
Abstract
Pruritis is an itchy feeling on or under your skin. This pamphlet explains what causes pruritis in people with CKD, what the symptoms are, how you can prevent it, and how your kidney team will treat it.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
2385
Less detail
Nova Scotia Health Authority. Emergency Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0240
Available Online
View Pamphlet
This pamphlet explains what causes kidney stones, symptoms, what to expect while you are in the Emergency Department, and follow-up.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Emergency Services
Alternate Title
Renal colic
Renal calculi
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Kidney Calculi
Subjects (LCSH)
Kidneys--Calculi
Specialty
Emergency
Abstract
This pamphlet explains what causes kidney stones, symptoms, what to expect while you are in the Emergency Department, and follow-up.
Responsibility
Prepared by: Emergency Services
Pamphlet Number
0240
Less detail

Acute hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35036
Nova Scotia Health Authority. QEII. Nephrology Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1151
Available Online
View Pamphlet
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Nephrology Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Acute Kidney Injury
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Acute renal failure
Abstract
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
Responsibility
Prepared by: Nephrology Services
Pamphlet Number
1151
Less detail

In-centre hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35162
Nova Scotia Health Authority. Central Zone. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1220
Available Online
View Pamphlet
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Renal Program
Alternate Title
In centre hemodialysis
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (24 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Kidneys--Diseases
Specialty
Nephrology
Abstract
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also included.
Notes
Previous titles: Renal (dialysis) patient handbook, Hemodialysis patient handbook
Responsibility
Prepared by: Renal Program, Central Zone
Pamphlet Number
1220
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Renal anemia
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

Tums (calcium carbonate) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35431
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1514
Available Online
View Pamphlet
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Calcium Carbonate - therapeutic use
Kidney Diseases - drug therapy
Subjects (LCSH)
Calcium carbonate
Kidneys--Diseases
Specialty
Nephrology
Abstract
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
Notes
Tums (calcium carbonate) and kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1514
Less detail

Over-the-counter medications and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1636
Available Online
View Pamphlet
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Nonprescription Drugs
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Drugs, Nonprescription
Chronic renal failure
Abstract
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why you should not take any herbal or natural health products is included.
Notes
Previous title: Over-the-counter medications & chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1636
Less detail

Hepatitis B vaccine and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36604
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1425
Available Online
View Pamphlet
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Hepatitis B - prevention & control
Kidney Diseases
Subjects (LCSH)
Hepatitis B vaccine
Kidneys--Diseases
Specialty
Nephrology
Abstract
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get vaccinated. This pamphlet explains what the hepatitis B vaccine is, possible side effects, and who should not get the vaccine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1425
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amoun…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1468
Less detail

One-Alpha® (alfacalcidol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1470
Available Online
View Pamphlet
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can ca…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels of in the blood and weaker bones. One-Alpha® raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. One-Alpha® is a brand name for alfacalcidol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1470
Less detail

Using medications safely when you have kidney disease

https://libcat.nshealth.ca/en/permalink/chpams38205
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2357
Available Online
View Pamphlet
People with kidney disease often take many medications. These medications can help with your kidney disease and other medical conditions (like high blood pressure [hypertension] or diabetes). It is important to take your medications regularly and as told by your health care provider. This pamphlet explains what you need to know about your medications and non-prescription medications, how you can make sure your medications are OK for your level of kidney function, and what will happen if a medic…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Medications
Kidney Diseases - drug therapy
Subjects (LCSH)
Drugs
Kidney disease
Specialty
Medications
Nephrology
Abstract
People with kidney disease often take many medications. These medications can help with your kidney disease and other medical conditions (like high blood pressure [hypertension] or diabetes). It is important to take your medications regularly and as told by your health care provider. This pamphlet explains what you need to know about your medications and non-prescription medications, how you can make sure your medications are OK for your level of kidney function, and what will happen if a medication is not safe for your level of kidney function. Information about what to do if you have questions is included.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2357
Less detail

Are you on dialysis, taking blood thinners, and need an interventional radiology procedure?

https://libcat.nshealth.ca/en/permalink/chpams35344
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Vascular Access Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1444
Available Online
View Pamphlet
This pamphlet gives directions for dialysis patients on warfarin who are having an interventional radiology procedure. The pamphlet explains what an interventional radiology procedure is. Space is provided to write the name and date of your procedure, as well as instructions to follow before and after your procedure. Instructions about what to do if you notice any bleeding or bruising in the area of your body where the procedure was done are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Services
Nova Scotia Health Authority. QEII. Vascular Access Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Nephrology
Warfarin
Renal Dialysis
Radiology, Interventional
Subjects (LCSH)
Nephrology
Hemodialysis
Warfarin
Interventional radiology
Specialty
Nephrology
Abstract
This pamphlet gives directions for dialysis patients on warfarin who are having an interventional radiology procedure. The pamphlet explains what an interventional radiology procedure is. Space is provided to write the name and date of your procedure, as well as instructions to follow before and after your procedure. Instructions about what to do if you notice any bleeding or bruising in the area of your body where the procedure was done are included.
Notes
Previous title: Hemodialysis instead of dialysis
Previous title: Dialysis patients on Warfarin who need interventional radiology procedures
Responsibility
Prepared by: Pharmacy Services, Vascular Access Services
Pamphlet Number
1444
Less detail

45 records – page 1 of 3.